ASX - By Stock
|
OPT |
Re:
Analyst Upgrade
|
|
SaltySultana
|
88 |
47K |
3 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
88
|
47K
|
3
|
|
ASX - By Stock
|
SO4 |
Re:
EPA
|
|
SaltySultana
|
9 |
4.8K |
2 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
9
|
4.8K
|
2
|
|
ASX - By Stock
|
SO4 |
Re:
Ann: December 2020 Quarterly Report
|
|
SaltySultana
|
26 |
8.9K |
1 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
26
|
8.9K
|
1
|
|
ASX - By Stock
|
SO4 |
Re:
Ann: December 2020 Quarterly Report
|
|
SaltySultana
|
26 |
8.9K |
4 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
26
|
8.9K
|
4
|
|
ASX - By Stock
|
SO4 |
Re:
Ann: December 2020 Quarterly Report
|
|
SaltySultana
|
26 |
8.9K |
1 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
26
|
8.9K
|
1
|
|
ASX - By Stock
|
SO4 |
Re:
Ann: Lake Way Project nearing completion
|
|
SaltySultana
|
106 |
62K |
1 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
106
|
62K
|
1
|
|
ASX - By Stock
|
SO4 |
Env approval
|
|
SaltySultana
|
0 |
301 |
1 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
0
|
301
|
1
|
|
ASX - By Stock
|
SO4 |
Re:
EPA
|
|
SaltySultana
|
12 |
2.9K |
0 |
06/11/20 |
06/11/20 |
ASX - By Stock
|
12
|
2.9K
|
0
|
|
ASX - By Stock
|
SO4 |
Re:
Director Liability
|
|
SaltySultana
|
34 |
10K |
1 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
34
|
10K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Files Registration Statement for Proposed US IPO
|
|
SaltySultana
|
10 |
4.9K |
0 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
10
|
4.9K
|
0
|
|
ASX - By Stock
|
CQE |
Goldman Sachs report
|
|
SaltySultana
|
2 |
1.5K |
4 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
2
|
1.5K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Present OPT-302 DME Clinical Data at ASRS 2020
|
|
SaltySultana
|
4 |
3.2K |
0 |
26/07/20 |
26/07/20 |
ASX - By Stock
|
4
|
3.2K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Appoints New Non-Executive Director
|
|
SaltySultana
|
5 |
2.3K |
4 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
5
|
2.3K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Index inclusion?
|
|
SaltySultana
|
1 |
675 |
0 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
1
|
675
|
0
|
|
ASX - By Stock
|
CQE |
Trouble on the horizon for CQE...
|
|
SaltySultana
|
1 |
770 |
0 |
08/06/20 |
08/06/20 |
ASX - By Stock
|
1
|
770
|
0
|
|
ASX - By Stock
|
SO4 |
Re:
Ann: March 2020 Quarterly Report
|
|
SaltySultana
|
82 |
32K |
5 |
04/06/20 |
04/06/20 |
ASX - By Stock
|
82
|
32K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
End May 2020 results
|
|
SaltySultana
|
14 |
6.7K |
1 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
14
|
6.7K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
SaltySultana
|
12 |
3.8K |
1 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
12
|
3.8K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
What matters most? Acuity or Duration? What if Opthea was wrong?
|
|
SaltySultana
|
16 |
8.0K |
3 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
16
|
8.0K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
1 year Price target?
|
|
SaltySultana
|
43 |
22K |
1 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
43
|
22K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Genentech success
|
|
SaltySultana
|
5 |
2.2K |
0 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
5
|
2.2K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Genentech success
|
|
SaltySultana
|
5 |
2.2K |
0 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
5
|
2.2K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
1 year Price target?
|
|
SaltySultana
|
43 |
22K |
3 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
43
|
22K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
1 year Price target?
|
|
SaltySultana
|
43 |
22K |
2 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
43
|
22K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
1 year Price target?
|
|
SaltySultana
|
43 |
22K |
6 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
43
|
22K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Recruitment in Ph2a Trial of OPT-302 in DME
|
|
SaltySultana
|
72 |
101K |
0 |
27/02/20 |
27/02/20 |
ASX - By Stock
|
72
|
101K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Present at SVB Leerink Healthcare Conference
|
|
SaltySultana
|
24 |
124K |
13 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
24
|
124K
|
13
|
|
ASX - By Stock
|
SO4 |
Re:
Lake way is flooded
|
|
SaltySultana
|
42 |
30K |
0 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
42
|
30K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Recruitment in Ph2a Trial of OPT-302 in DME
|
|
SaltySultana
|
72 |
101K |
2 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
72
|
101K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
court listing
|
|
SaltySultana
|
8 |
13K |
2 |
21/01/20 |
21/01/20 |
ASX - By Stock
|
8
|
13K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Opthea’s Star Brightens
|
|
SaltySultana
|
44 |
20K |
1 |
18/11/19 |
18/11/19 |
ASX - By Stock
|
44
|
20K
|
1
|
|
ASX - By Stock
|
SO4 |
MST Access broker report
|
|
SaltySultana
|
4 |
3.5K |
4 |
17/10/19 |
17/10/19 |
ASX - By Stock
|
4
|
3.5K
|
4
|
|